全、新、優(yōu)、品、好四大特點(diǎn)：

磷酸化p21激活激酶3抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

磷酸化p21激活激酶3抗體費(fèi)用 英文名稱  Anti-phospho-PAK3(Ser139)

中文名稱  磷酸化p21激活激酶3抗體費(fèi)用 

別    名 PAK3_HUMAN; Beta PAK; bPAK; CDKN1A; hPAK3; Mental retardation X linked 30; MRX30; MRX47; Oligophrenin 3; OPHN3; p21 activated kinase 3; p21 CDKN1A activated kinase 3; PAK-3; PAK3 p21 protein (Cdc42/Rac)-activated kinase 3; PAK3beta; Pak65alpha; Pak65beta; Serine threonine protein kinase PAK 3; Stk4.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Cow, Horse, Rabbit

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域    細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶 G蛋白信號(hào)

蛋白分子量  predicted molecular weight: 62kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human PAK3 around the phosphorylation site of (Ser139)

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化p21激活激酶3抗體費(fèi)用 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell.

P21-activated kinase (PAK) is actually a family of serine/threonine protein kinases, members of which are activated by small molecular weight GTPases. The three most common isoforms are PAK 1, PAK 2, and PAK 3 (also known as alpha PAK, gamma PAK, and beta PAK, respectively). These kinases contain numerous regulatory elements that trigger diverse signaling processes such as those initiated by activated GTPases, interaction with Src homology 3 (SH3) domains, and caspase mediated proteolytic cleavage. Autophosphorylation of serine 141 (serine 144 for PAK 1 and serine 139 PAK 3), catalyzed by Cdc42, is required for activation of PAK.

Function : Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, or cell cycle regulation. Plays a role in dendrite spine morphogenesis as well as synapse formation and plasticity. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration. Additionally, phosphorylates TNNI3/troponin I to modulate calcium sensitivity and relaxation kinetics of thin myofilaments.

Subunit : Interacts tightly with GTP-bound but not GDP-bound CDC42/p21 and RAC1. Shows highly specific binding to the SH3 domains of phospholipase C-gamma and of adapter protein NCK. Interacts with the C-terminal of APP (By similarity). Interacts with ARHGEF6 and ARHGEF7.

Tissue Specificity : Restricted to the nervous system. Highly expressed in postmitotic neurons of the developing and postnatal cerebral cortex and hippocampus.

Post-translational modifications : Autophosphorylated when activated by CDC42/p21.

DISEASE : Mental retardation, X-linked 30 (MRX30) [MIM:300558]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. Note=The disease is caused by mutations affecting the gene represented in this entry.

Similarity : Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.

Contains 1 CRIB domain.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: O75914.2

PAK1-3蛋白具有廣泛的生物學(xué)功能,也是一個(gè)保守的絲氨酸/蘇氨酸蛋白激酶,參與許多重要的細(xì)胞活動(dòng)。包括細(xì)胞骨架的動(dòng)力學(xué)調(diào)節(jié),細(xì)胞移動(dòng),生存和凋亡,細(xì)胞周期,基因轉(zhuǎn)錄調(diào)節(jié),細(xì)胞生長(zhǎng)信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)化等。

實(shí)驗(yàn)流程：

正在熱銷的相關(guān)產(chǎn)品：

Anti-Phospho- Beta-Catenin (Ser33/37) /FITC 熒光素標(biāo)記兔抗人、大、小鼠磷酸化β 連環(huán)素蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-HCMV UL49/FITC 熒光素標(biāo)記人巨細(xì)胞病毒UL49抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh CENPT 著絲粒蛋白T抗體 規(guī)格 0.2ml

Tie1/JTK14 peptide 上皮生長(zhǎng)因子樣域酪酸激酶1抗原 0.5mg

IGF1R 英文名稱： 樣生長(zhǎng)因子I受體抗體 0.1ml

Rhesus antibody Rh TIRAP 白細(xì)胞介素1受體銜接蛋白抗體 規(guī)格 0.2ml

Anti-HCMV UL49/FITC 熒光素標(biāo)記人巨細(xì)胞病毒UL49抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-IL-18R Alpha/FITC 熒光素標(biāo)記白細(xì)胞介素-18受體α鏈抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-Phospho-Raptor (Ser792) /FITC 熒光素標(biāo)記磷酸化mTOR相關(guān)調(diào)控蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh AP2M1/AP-2 接頭相關(guān)蛋白復(fù)合體AP-2μ鏈1抗體 規(guī)格 0.2ml

Rabbit anti-mouse Kappa light chain/Alexa Fluor 555 Alexa Fluor 555標(biāo)記的兔抗小鼠k鏈 0.1ml

Grpa 英文名稱： 半乳糖凝集素相關(guān)蛋白A抗體 0.2ml

Rhesus antibody Rh Rabbit Anti-human IgM/Bio 生物素標(biāo)記的兔抗人IgM 規(guī)格 0.3ml

Anti-Phospho-Raptor (Ser792) /FITC 熒光素標(biāo)記磷酸化mTOR相關(guān)調(diào)控蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

OSM(Mouse Oncostatin-M) ELISA KIT 小鼠抑瘤素MMulti-class antibodies規(guī)格： 48T

Anti-CD5/FITC 熒光素標(biāo)記CD5抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh EAAT2 膠質(zhì)細(xì)胞谷氨酸運(yùn)載蛋白2抗體 規(guī)格 0.1ml

EPBV IgM 病毒 IgM(間接法二步法)

phospho-MYL9(Thr19) 英文名稱： 磷酸化肌球蛋白輕鏈9抗體 0.1ml

ABP 英文名稱： 雄激素結(jié)合蛋白抗體 0.1ml

Anti-CD5/FITC 熒光素標(biāo)記CD5抗體IgGMulti-class antibodies規(guī)格： 0.2ml

CL-00025637(人細(xì)胞)5×106cells/瓶×2

NGF Others Mouse 小鼠 β-NGF / Beta-NGF CHO細(xì)胞裂解液 (陽(yáng)性對(duì)照)

動(dòng)物上皮細(xì)胞生長(zhǎng)添加物-aEpiCGS-2-a

荷蘭黑白花奶牛牛肺細(xì)胞;DCL1 ，SPA-A1細(xì)胞 SCaBER(膀胱鱗癌細(xì)胞)

EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KM0501

FZD5 Others Human 人 Frizzled-5 / FZD5 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

Ca Ski, 人細(xì)胞

EPHA2 Others Human 人 EphA2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

人胚腎細(xì)胞-F克隆;293F

HK-2C細(xì)胞，人胚腎上皮細(xì)胞 貂肺上皮細(xì)胞,Mv.1.Lu(NBL-7)細(xì)胞 CL-0365HuTu-80(人十二脂腸腺癌)5×106cells/瓶×2

BE(2)-M17(人神經(jīng)母細(xì)胞瘤細(xì)胞) 5×106cells/瓶×2

HOB-c 人成骨細(xì)胞(HOB) 500,000cells 人真皮成纖維母細(xì)胞-新生HDF-n

磷酸化p21激活激酶3抗體費(fèi)用 EREG Others Human 人 Epiregulin / EREG 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

人絨毛間葉成纖維細(xì)胞總RNAHVMF NA

Eca-109 人細(xì)胞

CL-0393NCI-H209(人小細(xì)胞細(xì)胞)5×106cells/瓶×2

MA, 小鼠星形膠質(zhì)細(xì)胞

人永生化淋巴細(xì)胞;CNLMG-B5538LC 人肝動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基 100mL

技術(shù)外包服務(wù):

★磷酸化p21激活激酶3抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。